Correlation Between Lotus Health and Cathay Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lotus Health and Cathay Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lotus Health and Cathay Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lotus Health Group and Cathay Biotech, you can compare the effects of market volatilities on Lotus Health and Cathay Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lotus Health with a short position of Cathay Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lotus Health and Cathay Biotech.

Diversification Opportunities for Lotus Health and Cathay Biotech

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between Lotus and Cathay is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Lotus Health Group and Cathay Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cathay Biotech and Lotus Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lotus Health Group are associated (or correlated) with Cathay Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cathay Biotech has no effect on the direction of Lotus Health i.e., Lotus Health and Cathay Biotech go up and down completely randomly.

Pair Corralation between Lotus Health and Cathay Biotech

Assuming the 90 days trading horizon Lotus Health Group is expected to under-perform the Cathay Biotech. In addition to that, Lotus Health is 3.47 times more volatile than Cathay Biotech. It trades about -0.04 of its total potential returns per unit of risk. Cathay Biotech is currently generating about -0.06 per unit of volatility. If you would invest  4,126  in Cathay Biotech on October 22, 2024 and sell it today you would lose (102.00) from holding Cathay Biotech or give up 2.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Lotus Health Group  vs.  Cathay Biotech

 Performance 
       Timeline  
Lotus Health Group 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Lotus Health Group are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Lotus Health sustained solid returns over the last few months and may actually be approaching a breakup point.
Cathay Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cathay Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Lotus Health and Cathay Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lotus Health and Cathay Biotech

The main advantage of trading using opposite Lotus Health and Cathay Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lotus Health position performs unexpectedly, Cathay Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cathay Biotech will offset losses from the drop in Cathay Biotech's long position.
The idea behind Lotus Health Group and Cathay Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios